SCHEMBL5872389

SCHEMBL5872389

CC1CN[C@H](C(N)=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12860960 1.00
SCHEMBL14290005 1.00
SCHEMBL8255222 1.00
SCHEMBL13480301 1.00
SCHEMBL16921041 1.00
SCHEMBL8248640 1.00
Hydrochloric Acid SCHEMBL23004591 0.98 CTSC (0.35)
Hydrochloric Acid SCHEMBL29013660 0.98 CTSC (0.35)
Hydrochloric Acid SCHEMBL29013662 0.98 CTSC (0.35)
SCHEMBL16399741 0.80 GLI1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400497-A1 3CLPRO PROTEASE INHIBITOR Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) 2024-07-17 EP disclosed
WO-2023036140-A1 3CLPRO PROTEASE INHIBITOR 上海齐鲁制药研究中心有限公司 2023-03-16 WO disclosed
US-7012075-B2 Cathepsin cysteine protease inhibitors MERCK & CO., INC. (US) 2006-03-14 US disclosed
WO-2005106011-A2 PROCESS FOR PREPARING DIPEPTIDYL IV INHIBITORS AND INTERMEDIATES THEREFOR BRISTOL-MYERS SQUIBB COMPANY (US) 2005-11-10 WO disclosed